Italian real life experience with ibrutinib: results of a large observational study on 77 relapsed/refractory mantle cell lymphoma. (Q55380607)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29805746%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

title

Italian real life experience with ibrutinib: results of a large observational study on 77 relapsed/refractory mantle cell lymphoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29805746%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

0 references

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29805746%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

Simone Ferrero

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29805746%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

Michele Merli

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29805746%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

Livio Trentin

30

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29805746%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

Lisa Argnani

32

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29805746%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

Pier Luigi Zinzani

33

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29805746%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

13

Rossella Paolini

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29805746%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

author name string

Alessandro Broccoli

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29805746%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

Alice Morigi

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29805746%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

Federico Sottotetti

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29805746%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

Manuel Gotti

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29805746%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

Michele Spina

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29805746%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

Stefano Volpetti

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29805746%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

Francesco Pisani

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29805746%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

Carlo Visco

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29805746%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

Vittorio Ruggero Zilioli

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29805746%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

Luca Baldini

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29805746%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

Nicola Di Renzo

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29805746%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

Patrizia Tosi

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29805746%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

Nicola Cascavilla

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29805746%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

Stefano Molica

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29805746%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

Fiorella Ilariucci

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29805746%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

Gian Matteo Rigolin

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29805746%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

Francesco D'Alò

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29805746%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

Anna Vanazzi

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29805746%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

Elisa Santambrogio

24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29805746%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

Roberto Marasca

25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29805746%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

Lucia Mastrullo

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29805746%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

Claudia Castellino

27

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29805746%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

Giovanni Desabbata

28

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29805746%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

Ilaria Scortechini

29

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29805746%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

Lucia Morello

31

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29805746%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

Francesco Spina

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29805746%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

language of work or name

English

0 references

publication date

4 May 2018

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29805746%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29805746%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

volume

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29805746%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

issue

34

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29805746%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

page(s)

23443-23450

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29805746%20AND%20SRC:MED&resulttype=core&format=json

Outcomes in 370 patients with mantle cell lymphoma treated with ibrutinib: a pooled analysis from three open-label studies

28 March 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5955107

Unification of de novo and acquired ibrutinib resistance in mantle cell lymphoma

10 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5955107

Predictive factors and outcomes for ibrutinib therapy in relapsed/refractory mantle cell lymphoma-a "real world" study

10 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5955107

Postibrutinib outcomes in patients with mantle cell lymphoma

10 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5955107

Ibrutinib versus temsirolimus in patients with relapsed or refractory mantle-cell lymphoma: an international, randomised, open-label, phase 3 study

10 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5955107

Long-term follow-up of MCL patients treated with single-agent ibrutinib: updated safety and efficacy results

10 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5955107

Patients with mantle cell lymphoma failing ibrutinib are unlikely to respond to salvage chemotherapy and have poor outcomes.

10 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5955107

Prolonged lymphocytosis during ibrutinib therapy is associated with distinct molecular characteristics and does not indicate a suboptimal response to therapy

10 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5955107

Targeting BTK with ibrutinib in relapsed or refractory mantle-cell lymphoma

10 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5955107

Improvement of Overall Survival in Advanced Stage Mantle Cell Lymphoma

10 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5955107

Lenalidomide in Pretreated Mantle Cell Lymphoma Patients: An Italian Observational Multicenter Retrospective Study in Daily Clinical Practice (the Lenamant Study).

10 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5955107

Practical management of ibrutinib in the real life: Focus on atrial fibrillation and bleeding.

12 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5955107

Observational study of lenalidomide in patients with mantle cell lymphoma who relapsed/progressed after or were refractory/intolerant to ibrutinib (MCL-004).

12 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5955107

12 August 2018

Mantle Cell Lymphoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5955107

Nordic MCL2 trial update: six-year follow-up after intensive immunochemotherapy for untreated mantle cell lymphoma followed by BEAM or BEAC + autologous stem-cell support: still very long survival but late relapses do occur.

12 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5955107

Revised response criteria for malignant lymphoma

12 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5955107

Newly diagnosed and relapsed mantle cell lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

12 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5955107

10.18632/ONCOTARGET.25215

30 November 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29805746%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29805746%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

1 reference